SCHEMBL24316788

SCHEMBL24316788

Cc1cnc2ccc(O)cn2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
GLA P06280 1/20 0.43
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
POLB P06746 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
AKR1B1 P15121 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688112 0.82 KDM4E (0.56) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL17383465 0.79 RXFP1 (0.43) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL24316522 0.79 ALDH1A1 (0.48) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL24316477 0.79 KDM4E (0.41) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL16368027 0.78 TGFBR1 (0.43) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL10518268 0.71 ALDH1A1 (0.56) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL22297931 0.70 KDM4E (0.33) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL27077073 0.70 TGFBR1 (0.48) MKNK1MKNK2
SCHEMBL24316808 0.70 POLB (0.41) KDM4EGAAGLAALDH1A1HPGD
SCHEMBL24316624 0.69 KDM4E (0.36) KDM4EGAAGLAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2024-03-21 US disclosed
EP-4214198-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF Hutchison Medipharma Limited (CN) 2023-07-26 EP disclosed
CN-116323582-A Heteroaromatic ring compounds and uses thereof 和记黄埔医药(上海)有限公司 2023-06-23 CN disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF CYP2D6, CYP3A7, CYP2F1 KDM4E 4085/4885GAA 323/4885GLA 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.